Differentiation Therapy
- 1 June 1992
- journal article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 6 (3), 687-706
- https://doi.org/10.1016/s0889-8588(18)30336-8
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Effects of the Differentiating Agent Hexamethylene Bisacetamide on Normal and Myelodysplastic Hematopoietic ProgenitorsJNCI Journal of the National Cancer Institute, 1990
- Identification of a second human retinoic acid receptorNature, 1988
- Disappearance of Trisomy 8 after Alpha-2 Interferon in a Patient with Myelodysplastic SyndromeNew England Journal of Medicine, 1988
- A human retinoic acid receptor which belongs to the family of nuclear receptorsNature, 1987
- INTERFERONS AND THEIR ACTIONSAnnual Review of Biochemistry, 1987
- Monosomy 7 in Granulocytes and Monocytes in Myelodysplastic SyndromeNew England Journal of Medicine, 1987
- Synthetic studies of vitamin D3 analogues. VIII Synthesis of 22-oxavitamin D3 analogues.CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
- The role of interferon-γ in induction of differentiation of human myeloid leukemia cell lines, ML-1 and HL-60Biochemical and Biophysical Research Communications, 1984
- Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60European Journal of Cancer and Clinical Oncology, 1983
- A fluorinated vitamin D3 analog with biopotency greater than 1α,25-dihydroxy vitamin D3Biochemical and Biophysical Research Communications, 1980